NIDA INVEST Fellow Wins EMCDDA Scientific Writing Award

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has selected an article by 2017 NIDA INVEST Drug Abuse Research Fellow Judit Tirado-Muñoz, Ph.D., Spain, for a 2018 Excellence in Scientific Writing Award. Dr. Tirado-Muñoz and colleagues examined psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe. The authors found that lifetime psychiatric comorbidity occurred almost three times more frequently among women who reported sharing needles and syringes (OR 2.65 95% CI 1.07–6.56). Women who experienced intimate partner violence were almost twice as likely to be diagnosed with post-traumatic stress disorder than women who were not victims of intimate partner violence (OR 1.95 95% CI 1.10–3.48). The article was published in the Archives of Women’s Mental Health (2018) 21:259-269. Dr. Tirado-Muñoz is spending her INVEST fellowship with Daniel Werb, Ph.D., University of California San Diego. She is conducting secondary data analysis on the associations among injection drug use, intimate partner violence, and psychiatric comorbidities in the multi-country, mixed-methods Preventing Injecting by Modifying Existing Responses (PRIMER) study. The EMCDDA award recognizes high-quality research and writing on illicit drug use. Papers are selected in five categories: 1) basic biological, neurobiological, and behavioral research; 2) population-based and clinical epidemiology; 3) markets and drug cultures; 4) demand reduction interventions; and 5) drug policy and supply reduction interventions. The scientific writing award winners will be invited to present their research at the Lisbon Addictions 2019 conference, which will be held October 23–25, 2019.